1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-114192 TGFβRI-IN-1

TGF-β Receptor

Cancer

2019-06 TGFβRI-IN-1
HY-114300 DSP-0565

Others

Neurological Disease

2019-06 DSP-0565
HY-13241A Ralimetinib

p38 MAPK

Cancer

2019-06 Ralimetinib
HY-124136 WYC-209

RAR/RXR

Cancer

2019-06 WYC-209
HY-114194 CCR1 antagonist 7

CCR

Inflammation/Immunology

2019-06 CCR1 antagonist 7
HY-122243 IU1-47

Deubiquitinase

Neurological Disease

2019-06 IU1-47
HY-120000 MS402

Epigenetic Reader Domain

Cancer

2019-06 MS402
HY-117491 BRD4 Inhibitor-10

Epigenetic Reader Domain

Cancer

2019-06 BRD4 Inhibitor-10
HY-114193 CCR1 antagonist 6

CCR

Inflammation/Immunology

2019-06 CCR1 antagonist 6
HY-108643 CMPD1

MAPKAPK2 (MK2)

Cancer

2019-06 CMPD1
HY-N0368 Linalool

iGluR

Cancer;

Cardiovascular Disease

2019-06 Linalool
HY-103178 MRE3008F20

Adenosine Receptor

Cancer

2019-06 MRE3008F20
HY-110086 RWJ 50271

Integrin

Inflammation/Immunology

2019-06 RWJ 50271
HY-100954 2,4-Diamino-6-hydroxypyrimidine

Others

Inflammation/Immunology

2019-06 2,4-Diamino-6-hydroxypyrimidine
HY-107532 N-Nonyldeoxynojirimycin

Others

Metabolic Disease

2019-06 N-Nonyldeoxynojirimycin
HY-101457 JZP-430

MAGL

Metabolic Disease

2019-06 JZP-430
HY-101840A EIPA hydrochloride

TRP Channel; Sodium Channel

Cancer;

Inflammation/Immunology

2019-06 EIPA hydrochloride
HY-101310 SYM 2081

iGluR

Neurological Disease

2019-06 SYM 2081
HY-107523 WAY-213613

EAAT2

Neurological Disease

2019-06 WAY-213613
HY-103157 PD146176

Others; Autophagy

Cardiovascular Disease

2019-06 PD146176